ES2236738T3 - Composicion para mejorar la digestibilidad y la utilizacion de nutrientes. - Google Patents

Composicion para mejorar la digestibilidad y la utilizacion de nutrientes.

Info

Publication number
ES2236738T3
ES2236738T3 ES96920782T ES96920782T ES2236738T3 ES 2236738 T3 ES2236738 T3 ES 2236738T3 ES 96920782 T ES96920782 T ES 96920782T ES 96920782 T ES96920782 T ES 96920782T ES 2236738 T3 ES2236738 T3 ES 2236738T3
Authority
ES
Spain
Prior art keywords
enzyme
composition
lipase
activity
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96920782T
Other languages
English (en)
Spanish (es)
Inventor
Simon Lodewijk Scharpe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medzyme NV
Original Assignee
Medzyme NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8220345&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2236738(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medzyme NV filed Critical Medzyme NV
Application granted granted Critical
Publication of ES2236738T3 publication Critical patent/ES2236738T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Sewing Machines And Sewing (AREA)
ES96920782T 1995-05-31 1996-05-31 Composicion para mejorar la digestibilidad y la utilizacion de nutrientes. Expired - Lifetime ES2236738T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95201438 1995-05-31
EP95201438 1995-05-31

Publications (1)

Publication Number Publication Date
ES2236738T3 true ES2236738T3 (es) 2005-07-16

Family

ID=8220345

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96920782T Expired - Lifetime ES2236738T3 (es) 1995-05-31 1996-05-31 Composicion para mejorar la digestibilidad y la utilizacion de nutrientes.

Country Status (8)

Country Link
US (1) US6051220A (de)
EP (1) EP0828509B1 (de)
AT (1) ATE287725T1 (de)
AU (1) AU6221496A (de)
CA (1) CA2222682A1 (de)
DE (1) DE69634248T2 (de)
ES (1) ES2236738T3 (de)
WO (1) WO1996038170A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU750891B2 (en) 1996-12-06 2002-08-01 Aventis Pharmaceuticals Inc. Polypeptides encoded by a human lipase-like gene, compositions and methods
US6140475A (en) * 1997-04-11 2000-10-31 Altus Biologics Inc. Controlled dissolution crosslinked protein crystals
JP2000226335A (ja) * 1998-12-04 2000-08-15 Amano Pharmaceut Co Ltd 経口用酵素製剤、酵素含有食材及び酵素製剤の服用方法
US20010046493A1 (en) * 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
AUPS076502A0 (en) * 2002-02-26 2002-03-21 Ceramic Fuel Cells Limited A fuel cell gas separator plate
US7142464B2 (en) * 2003-04-29 2006-11-28 Saifun Semiconductors Ltd. Apparatus and methods for multi-level sensing in a memory array
US20070087086A1 (en) * 2003-12-02 2007-04-19 Novozymes A/S Method for producing potato products
CA2560613C (en) 2004-03-22 2015-11-24 Solvay Pharmaceuticals Gmbh Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
DK1755656T3 (da) * 2004-05-24 2010-10-04 Novozymes As Enzymer til farmaceutisk anvendelse
DK1809320T3 (da) 2004-10-14 2010-11-15 Cystic Fibrosis Foundation The Præparater indeholdende lipase, protease og amylase til behandling af pankreatisk insufficiens
EP1896057A2 (de) 2005-06-24 2008-03-12 Novozymes A/S Amylasen zur pharmazeutischen verwendung
PL2278002T3 (pl) * 2005-07-29 2017-12-29 Abbott Laboratories Gmbh Pankreatyna o zmniejszonej zawartości wirusowej
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
EP1935253A4 (de) * 2005-09-20 2009-09-02 Idemitsu Kosan Co Zusatzstoff für tierfutter
EP1932905A4 (de) * 2005-10-05 2010-01-06 Asahi Breweries Ltd Verfahren zur herstellung einer pilzkultur
US20100196344A1 (en) * 2005-10-14 2010-08-05 Cystic Fibrosis Foundation Therapeutics, Inc. Compositions and methods for treating pancreatic insufficiency
WO2007053619A2 (en) * 2005-11-01 2007-05-10 Bio-Cat, Inc. A composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrous as well as people suffering from pancreatic lipase insufficiency
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
PT2079445E (pt) * 2007-02-20 2016-02-29 Allergan Pharmaceuticals Internat Ltd Composições de enzimas digestivas estáveis
ES2732293T3 (es) 2007-02-22 2019-11-21 Childrens Hospital & Res Center At Oakland Formulaciones de ácidos grasos y métodos para el uso de las mismas
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
CA2707658A1 (en) * 2007-12-04 2009-06-11 Novozymes A/S Protease variants for pharmaceutical use
WO2009109856A2 (en) 2008-03-07 2009-09-11 Axcan Pharma Inc. Method for detecting infectious parvovirus in pharmaceutical preparations
EP2328566A1 (de) * 2008-09-30 2011-06-08 DSM IP Assets B.V. Enzymzusammensetzung und deren anwendung bei der behandlung von pankreasinsuffizienz
WO2010130622A1 (en) * 2009-05-11 2010-11-18 Dsm Ip Assets B.V. Enzyme composition for the treatment of prancreatic insufficiency
KR20130050923A (ko) * 2010-03-19 2013-05-16 앱탈리스 파마 캐나다 아이엔씨. 위 내성 효소 제약 조성물
EA029101B1 (ru) 2010-10-01 2018-02-28 Апталис Фарма Лимитид Составы с низкой дозой панкрелипазы и кишечнорастворимым покрытием
CA2843556A1 (en) 2011-08-08 2013-02-14 Aptalis Pharma Ltd. Method for dissolution testing of solid compositions containing digestive enzymes
US8268305B1 (en) 2011-09-23 2012-09-18 Bio-Cat, Inc. Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
PL3398594T3 (pl) 2012-09-19 2024-11-04 Grespo Ab Kompozycje do ulepszenia funkcji mózgu
WO2014141121A1 (en) 2013-03-15 2014-09-18 Aptalis Pharma Ltd. Composition containing digestive enzymes and nutrients suitable for enteral administration
CA2919114A1 (en) 2013-07-22 2015-02-12 Aptalis Pharma Ltd. High potency pancreatin pharmaceutical compositions
EP3639846B1 (de) 2013-08-09 2022-09-28 Allergan Pharmaceuticals International Limited Verdauungsenzymzusammensetzung zur enteralen verabreichung
EP3003360B1 (de) 2013-11-05 2020-10-07 Allergan Pharmaceuticals International Limited Hochwirksame pharmazeutische pankreatinzusammensetzungen
EP3157568A1 (de) 2014-06-19 2017-04-26 Aptalis Pharma Limited Verfahren zur entfernung von viralen verunreinigungen aus pankreatischen extrakten
GB201501081D0 (en) 2015-01-22 2015-03-11 Cilian Ag Use of enzymes with a wide pH activity range as medicaments for promoting digestion
US20180028454A1 (en) 2015-02-04 2018-02-01 Abbvie Inc. Pharmaceutical compositions and methods of use thereof to treat pancreatic enzyme insufficiency
FR3079146B1 (fr) 2018-03-23 2020-04-17 Karim Ioualalen Formulation gastroprotectrice de complexes d’enzymes permettant de restaurer la fonction digestive.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1084431A (en) * 1964-05-06 1967-09-20 Analyses Et De Rech S Biolog M Improvements in and relating to lipases
DE2638088C3 (de) * 1976-08-24 1979-06-21 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt Verwendung von SuBmolkenpulver
FR2362863A1 (fr) * 1976-08-24 1978-03-24 Degussa Preparations de lipases a action amelioree et preparations medicales ameliorees contenant des lipases d'origine non animale
EP0387945B1 (de) * 1989-03-08 1993-11-03 Simon Lodewijk Scharpé Mischung zur Behandlung der von exokrinen Insuffizienz der Bauchspeicheldrüse und die Verwendung der genannten Mischung
BE1005445A3 (fr) * 1991-10-16 1993-07-27 Enzymes And Derivates Belgium Compositions enzymatiques d'aide a la digestion.
US5260074A (en) * 1992-06-22 1993-11-09 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof

Also Published As

Publication number Publication date
DE69634248T2 (de) 2006-01-12
WO1996038170A1 (en) 1996-12-05
CA2222682A1 (en) 1996-12-05
EP0828509A1 (de) 1998-03-18
US6051220A (en) 2000-04-18
AU6221496A (en) 1996-12-18
EP0828509B1 (de) 2005-01-26
DE69634248D1 (de) 2005-03-03
ATE287725T1 (de) 2005-02-15

Similar Documents

Publication Publication Date Title
US6051220A (en) Composition to improve digestibility and utilization of nutrients
ES2614157T3 (es) Composiciones que contienen lipasa, proteasa y amilasa para el tratamiento de la insuficiencia pancreática
ES2345032T3 (es) Composicion que contiene lipasa no fungica, reticulada y metodos de uso.
ES2806098T3 (es) Procedimientos para el tratamiento dietético del síndrome del intestino irritable y la malabsorción de carbohidratos
US10596235B2 (en) Pharmaceutical preparation
US20190209667A1 (en) Method for diagnosing and treating dysautonomia and other dysautonomic conditions
ES2426258T3 (es) Composiciones farmacéuticas que comprenden bacterias que reducen oxalato
US20100196344A1 (en) Compositions and methods for treating pancreatic insufficiency
US20040057944A1 (en) Microbial enzyme mixtures useful to treat digestive disorders
Mischler et al. Comparison of effectiveness of pancreatic enzyme preparations in cystic fibrosis
ES2880602T3 (es) Comprimido orodispersable que contiene burlulipasa y composición farmacéutica preparada a partir de ella
CA2137674A1 (en) Use of enzymes, especially bromelain, in the treatment of diarrhoea
ES2618930T3 (es) Composición que comprende diaminooxidasa para la prevención de los síntomas de la resaca
EP0387945B1 (de) Mischung zur Behandlung der von exokrinen Insuffizienz der Bauchspeicheldrüse und die Verwendung der genannten Mischung
Park et al. Digestive enzyme supplementation in prescription drugs, over-the-counter drugs, and enzyme foods
ES2349086T3 (es) Enzimas para uso farmacéutico.
JP2005239737A (ja) 生活の質を改善する新規医薬組成物の製法および用途
ES2924573A1 (es) Sistema de administracion en multiples sitios para administracion diferencial en el tracto gastrointestinal
TITGGI Polypeptid ala ser tyr
HK1145462A (en) Compositions containing lipase, protease and amylase for treating pancreatic insufficiency
HK1004193B (en) Use of enzymes, especially bromelain, in the treatment of non-infectious diarrhoea
KR20030067752A (ko) 미생물 효소의 신규 혼합물